Inflammatory Bowel Disease Advice Lines: A Scoping Review

炎症性肠病咨询热线:范围界定综述

阅读:1

Abstract

BACKGROUND AND AIMS: Telephone or email advice lines offer a service that bridges primary and specialist care provision, supporting the needs of those living with an unpredictable disease course. This scoping review aimed to systematically synthesize published evidence with regard to Inflammatory Bowel Disease advice line services and to identify gaps in research to inform further work. METHODS: A scoping review was undertaken in accordance with the patterns, advances, gaps, evidence, and research framework. Databases searched included CINAHL, PubMed, and EMBASE. Inclusion/exclusion criteria were applied by 2 reviewers independently. Data were collected using a predefined matrix, from which the framework was applied as a means of systematically collating patterns, advances, gaps, evidence, and research recommendations. RESULTS: Seventeen full-text publications and 22 abstracts published between 2006 and 2023 were included. Four overarching patterns were identified: advice lines as a complex intervention, drivers for advice line encounters, patient outcomes, and economic impact of advice lines. CONCLUSIONS: The current evidence landscape lacks empirical research supporting the clinical and economic effectiveness of advice lines. Inflammatory bowel disease advice lines are commonly a nurse-led service functioning as a complex intervention, supporting both administrative and clinical issues. They appear pivotal in preventing use of acute services and escalating or re-directing care, including treatment, investigation, and advice. Further research should focus on robust clinical and economic evaluation for patients and services, exploring patient experience of advice line services, including barriers and facilitators, and characterizing those who do not currently access the service.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。